Remdesivir Not Silver Bullet, But Important Part Of COVID Treatment - Int'l Research Body

Simple item page
dc.contributor.authorAli, Mohammad
dc.contributor.authorSeley-Radtke, Katherine
dc.date.accessioned2025-07-30T19:22:56Z
dc.date.issued2020-05-15
dc.description.urihttps://www.urdupoint.com/en/world/remdesivir-not-silver-bullet-but-important-p-921678.html
dc.format.extent4 pages
dc.genrearticles
dc.identifierdoi:10.13016/m20sfv-cpqc
dc.identifier.citationAli, Mohammad and Katherine Seley-Radtke. "Remdesivir Not Silver Bullet, But Important Part Of COVID Treatment - Int'l Research Body". UrduPoint. May 15, 2020. https://www.urdupoint.com/en/world/remdesivir-not-silver-bullet-but-important-p-921678.html
dc.identifier.urihttp://hdl.handle.net/11603/39627
dc.language.isoen_US
dc.publisherUrduPoint
dc.relation.isAvailableAtThe University of Maryland, Baltimore County (UMBC)
dc.relation.ispartofUMBC Faculty Collection
dc.relation.ispartofUMBC Chemistry & Biochemistry Department
dc.rightsThis item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
dc.subjectCOVID
dc.subjectRemdesivir
dc.subjectcoronavirus
dc.subjectmedication
dc.titleRemdesivir Not Silver Bullet, But Important Part Of COVID Treatment - Int'l Research Body
dc.typeText
dcterms.creatorhttps://orcid.org/0000-0002-0154-3459

Files

Collections

UMBC Faculty Collection
UMBC Chemistry & Biochemistry Department